Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Idursulfase-IT in Hunter Syndrome
NCT00920647Phase 2Completed
- Sponsor
- Takeda
- Start
- Nov 2009
- Primary completion
- Oct 2012
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of idursulfase in mucopolysaccharidosis type II, sponsored by Takeda. Started Nov 2009; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT00920647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920647.